Skip to Content

AD: New Knowledge About Type 2 Inflammation and Skin Barrier Deficiency

In this MEDtalk, Stephan Weidinger, Professor of Dermatology from Kiel, gives his perspective on the importance of Type 2 inflammation and skin barrier deficiency in the development and choice of treatment for patients with atopic dermatitis based on the knowledge of which cytokines are most important for the management of AD.

Stephan Weidinger

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top